Classic psychedelics refer to substances such as lysergic acid diethylamide (LSD),
psilocybin, ayahuasca, and mescaline, which induce altered states of consciousness by …

Bulimia nervosa is an eating disorder characterised by marked impairment to one's physical
health and social functioning, as well as high rates of chronicity and comorbidity. This …

Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) details metabolic, behavioral health, and disordered eating comorbidities associated …

Glucagon‐like peptide‐1 receptor agonists (GLP‐1As) are being used as approved or off‐
label treatments for weight loss. As such, there has been increasing concern about the …

Introduction Attention deficit hyperactivity disorder (ADHD) medication has proven effective
for treating ADHD in adults, nonetheless previous studies have shown high rates of …

As Faculty of the British Association for Psychopharmacology course on child and
adolescent psychopharmacology, we present here what we deem are the most common …

Background There is emerging evidence that stimulants warrant further investigation as a
treatment for bulimia nervosa (BN) including a recent open-label feasibility trial examining …

Psychological disorders and dramatic social problems are serious concerns regarding the
abuse of amphetamine and its stimulant derivatives worldwide. Consumers of such drugs …

This study examined the proportion of Canadian adults who were on psychiatric medication
prior to entering specialized outpatient care for an eating disorder, the types and …

Background Loss of control eating (LOC-E) in youth predicts the later development of full-
syndrome binge-eating disorder (BED), and therefore, could be a relevant target for …